Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Indiana University
Study ID
NCT07336381
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Peripheral Arterial Disease
  • Peripheral Neuropathy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Replexa shortwave diathermy — DEVICE
    Treatment with home use of the Replexa+ shortwave diathermy device twice daily for 3 months.

Study Details

This research project is designed to see if treatment with the Replexa+ shortwave diathermy device daily for 3 months will improve blood flow in the lower legs and feet of patients diagnosed with peripheral artery disease and peripheral neuropathy.

Key Dates

Start date
Jul 1, 2026
Status verified
May 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention
    In-home shortwave diathermy treatment.

Primary Outcome Measure

Compare baseline and post-treatment lower extremity arterial dopplers to determine change in lower extremity arterial perfusion. [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Richard L. Roudebush Veterans Affairs Medical CenterIndianapolisIndiana46202
Kristen Evans, RN, CCRC
[email protected]
317-988-9548
Michael P. Murphy, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Indianapolis, IN

By research site
Richard L. Roudebush Veterans Affairs Medical Center· Indianapolis, IN

Related Studies